As of the latest SEC filings, Roivant Sciences Ltd. (ROIV) is held by 389 institutional funds. The largest fund shareholder is Fidelity Growth Company Fund (FGCKX), holding an estimated $630,245,625.10 in market value, representing 0.76% of its portfolio.
Funds holding Roivant Sciences Ltd. (ROIV)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ROIV
- CIK:
- 0001635088
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.76% | $630,245,625.10 | 21,777,665 | Feb 28, 2026 | Apr 24, 2026 |
|
IJH
iShares Core S&P Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.39% | $413,518,258.90 | 14,928,457 | Mar 31, 2026 | May 26, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $409,746,211.40 | 14,792,282 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.18% | $297,129,811.60 | 10,726,708 | Mar 31, 2026 | May 28, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.76% | $176,897,891.56 | 6,112,574 | Feb 28, 2026 | Apr 24, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.43% | $166,231,578.00 | 6,001,140 | Mar 31, 2026 | May 28, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.76% | $160,197,370.00 | 5,535,500 | Feb 28, 2026 | Apr 24, 2026 |
|
MSGUX
GROWTH PORTFOLIO
|
MF | Morgan Stanley | 4.60% | $151,305,903.90 | 5,462,307 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.17% | $139,417,811.80 | 5,033,134 | Mar 31, 2026 | May 28, 2026 |
|
XMMO
Invesco S&P MidCap Momentum ETF
|
ETF | Invesco | 1.92% | $130,523,266.44 | 4,574,948 | Apr 30, 2026 | Jun 26, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 1.13% | $123,200,542.10 | 4,447,673 | Mar 31, 2026 | May 28, 2026 |
|
-
Morgan Stanley Discovery Portfolio
|
ETF | Independent / Boutique | 9.44% | $105,678,934.80 | 3,815,124 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 1.24% | $100,898,828.90 | 3,642,557 | Mar 31, 2026 | May 28, 2026 |
|
MDY
SPDR S&P MidCap 400 ETF Trust
|
ETF | State Street (SPDR) | 0.39% | $94,136,289.40 | 3,398,422 | Mar 31, 2026 | Jun 1, 2026 |
|
FCNTX
Fidelity Contrafund
|
MF | Fidelity | 0.06% | $93,976,321.90 | 3,392,647 | Mar 31, 2026 | May 26, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.07% | $79,339,364.90 | 2,864,237 | Mar 31, 2026 | May 28, 2026 |
|
MPEGX
Discovery Portfolio
|
MF | Morgan Stanley | 9.92% | $73,708,619.70 | 2,660,961 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.16% | $66,377,681.14 | 2,293,631 | Feb 28, 2026 | Apr 24, 2026 |
|
SPMD
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF
|
ETF | State Street (SPDR) | 0.39% | $61,013,488.10 | 2,202,653 | Mar 31, 2026 | May 28, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.26% | $57,095,148.96 | 2,001,232 | Apr 30, 2026 | Jun 26, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 1.07% | $57,090,487.86 | 1,972,719 | Feb 28, 2026 | Apr 24, 2026 |
|
-
Transamerica Capital Growth
|
ETF | Transamerica | 4.25% | $53,608,297.95 | 1,879,015 | Apr 30, 2026 | Jun 18, 2026 |
|
CPODX
Morgan Stanley Insight Fund
|
MF | Morgan Stanley | 4.77% | $53,370,975.00 | 1,926,750 | Mar 31, 2026 | May 28, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.09% | $45,111,333.60 | 1,628,568 | Mar 31, 2026 | May 28, 2026 |
|
FSMDX
Fidelity Mid Cap Index Fund
|
MF | Fidelity | 0.09% | $44,870,643.09 | 1,572,753 | Apr 30, 2026 | Jun 26, 2026 |
Advertisement (320x50)